TickerFactsScreenerDevelopers

HERON THERAPEUTICS, INC. /DE/ (HRTX) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $2.0K2010: $78.0K2011: $513.0K2012: $972.0K2013: $1.69M2014: $1.44M2015: $1.09M2016: $3.13M2017: $2.55M2018: $9.17M2019: $7.15M2020: $6.81M2021: $3.02M2022: $1.82M2023: $1.54M2024: $1.71M2025: $317.0K$317.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$317.0K-81.4%
2024$1.71M+10.4%
2023$1.54M-15.3%
2022$1.82M-39.6%
2021$3.02M-55.6%
2020$6.81M-4.8%
2019$7.15M-22.0%
2018$9.17M+259.2%
2017$2.55M-18.6%
2016$3.13M+188.7%
2015$1.09M-24.5%
2014$1.44M-14.7%
2013$1.69M+73.4%
2012$972.0K+89.5%
2011$513.0K+557.7%
2010$78.0K+3800.0%
2009$2.0K—